Abstract Background: Coronavirus disease-19 (COVID-19) is an ongoing global pandemic
caused by the “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), which was …

Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and
middle‐aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and …

This evidence‐and consensus‐based guideline was developed following the methods
recommended by Cochrane and the Grading of Recommendations Assessment …

Background The infection caused by the recently identified SARS‐CoV‐2, called
coronavirus disease‐19 (COVID‐19), has rapidly spread throughout the world. With the …

The cutaneous manifestations of COVID‐19 patients have been increasingly reported, but
not summarized, and the potential mechanisms remain to be investigated. Herein, we …

Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …

Urticaria is a common clinical condition presenting with wheals (hives), angioedema, or
both. Urticaria has a complex pathogenesis, along with a high disease burden, a significant …

The first cases of the coronavirus disease (COVID‐19) appeared in Wuhan, China, in
December 2019. COVID‐19 was declared a pandemic in March 2020. Cutaneous …

Chronic spontaneous urticaria (CSU) is often associated with organ specific autoimmunity
but is rarely caused by food allergy. Colourings and preservatives in pre-packaged foods, so …

The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial
recognized symptoms were respiratory, sometimes culminating in severe respiratory distress …